Conversely, PIEZO1 inhibition or knockdown diminishes NF-κB activation, dampens chemokine secretion, and curtails Th17 cell differentiation, highlighting PIEZO1 as a prospective therapeutic target in psoriasis. Here, NFKB1 is linked to psoriasis.